Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysine its cell wall

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 2249-2252

  Stucki, A ^a   Cottagnoud, M ^b   Winkelmann, V ^a   Schaffner, T ^a   Cottagnoud, P ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Spital Bern Ziegler ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CHOLINE; DAPTOMYCIN; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOLYSIS; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOLYSIS; CEFTRIAXONE; CELL WALL; CEREBROSPINAL FLUID; CHOLINE; DAPTOMYCIN; DISEASE MODELS, ANIMAL; HUMANS; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; RABBITS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; TRITIUM;

EID: 34250209874     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01000-06     Document Type: Article

References (13)

1. Canepari, P., M. Boaretti, M. M. Lleo, and G. Satta. 1990. Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032). Antimicrob. Agents Chemother. 34:1220-1226.
2. Cottagnoud, P., M. Pfister, F. Acosta, M. Cottagnoud, L. Flatz, F. Kuhn, H. P. Muller, and A. Stucki. 2004. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob. Agents Chemother. 48:3928-3933.
3. Dacey, R. G., and M. A. Sande. 1974. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob. Agents Chemother. 6:437-441.
4. Fischer, H., and A. Tomasz. 1984. Production and release of peptidoglycan and wall teichoic acid polymers in pneumococci treated with beta-lactam antibiotics. J. Bacteriol. 157:507-513.
5. Fischer, W. 2000. Pneumococcal lipoteichoic and teichoic acid, p. 155-177. In A. Tomasz (ed.), Streptococcus pneumoniae, molecular biology and mechanisms of disease. Mary Ann Liebert, Inc., Larmont, NY.
6. Gerber, P., A. Stucki, F. Acosta, M. Cottagnoud, and P. Cottagnoud. 2006. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J. Antimicrob. Chemother. 57:720-723.
7. Grandgirard, D., C. Schuerch, P. Cottagnoud, and S. L. Leib. 2005. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 742.
8. Grimwood, K., V. A. Anderson, L. Bond, C. Catroppa, R. L. Hore, E. H. Keir, T. Nolan, and D. M. Roberton. 1995. Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics 95:646-656.
9. Koedel, U., W. M. Scheld, and H. W. Pfister. 2002. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect. Dis. 2:721-736.
10. Nau, R., K. Kaye, M. Sachdeva, E. R. Sande, and M. G. Tauber. 1994. Rifampin for therapy of experimental pneumococcal meningitis in rabbits. Antimicrob. Agents Chemother. 38:1186-1189.
11. Schuchat, A., K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, B. A. Perkins, et al. 1997. Bacterial meningitis in the United States in 1995. N. Engl. J. Med. 337:970-976.
12. Tuomanen, E., H. Liu, B. Hengstler, O. Zak, and A. Tomasz. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect. Dis. 151:859-868.
13. Tuomanen, E., A. Tomasz, B. Hengstler, and O. Zak. 1985. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J. Infect. Dis. 151:535-540.